The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2023 | The prognostic value of serum paraprotein response kinetics in transplant-eligible NDMM
In this video, Luis-Esteban Tamariz-Amador, MD, University Clinic of Navarra, Pamplona, Spain, discusses research exploring the prognostic value of M-component kinetics in patients with transplant-eligible newly diagnosed multiple myeloma (NDMM). This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
